{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:16:29Z","timestamp":1791508589428,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.numecd.2024.09.015","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:45:07Z","timestamp":1726933507000},"page":"2771-2778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum uric acid and mortality in metabolic dysfunction-associated steatotic liver disease: Subgroup differences"],"prefix":"10.1016","volume":"34","author":[{"given":"Wenya","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-8175","authenticated-orcid":false,"given":"Wen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2024.09.015_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2024.09.015_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2024.09.015_bib3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2024.09.015_bib4","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2024.09.015_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.numecd.2024.09.015_bib6","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2024.09.015_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.numecd.2024.09.015_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.numecd.2024.09.015_bib9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2024.09.015_bib10","doi-asserted-by":"crossref","DOI":"10.5888\/pcd14.160287","article-title":"Metabolic syndrome prevalence by race\/ethnicity and sex in the United States, national Health and nutrition examination survey, 1988-2012","volume":"14","author":"Moore","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.numecd.2024.09.015_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001","article-title":"Cardiovascular consequences of metabolic syndrome","volume":"183","author":"Tune","year":"2017","journal-title":"Transl Res"},{"issue":"Suppl 3","key":"10.1016\/j.numecd.2024.09.015_bib12","first-page":"121s","article-title":"Relationship of metabolic risk factors and development of cardiovascular disease and diabetes","volume":"14","author":"Haffner","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.numecd.2024.09.015_bib13","article-title":"Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors","volume":"38","author":"Silveira","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.numecd.2024.09.015_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.09.015_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1631\/jzus.2007.B0593","article-title":"Relationship between hyperuricemia and metabolic syndrome","volume":"8","author":"Chen","year":"2007","journal-title":"J Zhejiang Univ - Sci B"},{"key":"10.1016\/j.numecd.2024.09.015_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.ATV.0000161274.87407.26","article-title":"Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals","volume":"25","author":"Ishizaka","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2024.09.015_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.numecd.2024.09.015_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/CLEP.S403314","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis","volume":"15","author":"Sun","year":"2023","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.numecd.2024.09.015_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2020.08.006","article-title":"Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: three longitudinal analyses","volume":"311","author":"Ma","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.09.015_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011578","article-title":"High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study","volume":"5","author":"Xu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2024.09.015_bib21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ajg.2013.104","article-title":"Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study","volume":"108","author":"Xu","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2024.09.015_bib22","series-title":"Analytic and reporting guidelines: the Third national Health and nutrition examination survey, NHANES III (1988-94)","year":"1996"},{"key":"10.1016\/j.numecd.2024.09.015_bib23","series-title":"Hepatic steatosis ultrasound images assessment procedures manual","year":"2010"},{"key":"10.1016\/j.numecd.2024.09.015_bib24","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1097\/HEP.0000000000000696","article-title":"Reply: a multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Lazarus","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2024.09.015_bib25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2024.09.015_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2024.09.015_bib27","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.09.015_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2024.09.015_bib29","series-title":"Instructions for classifying the underlying cause of death","year":"2016"},{"key":"10.1016\/j.numecd.2024.09.015_bib30","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/j.jhep.2023.12.009","article-title":"Uric acid may serve as the sixth cardiometabolic criterion for defining MASLD","volume":"80","author":"He","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2024.09.015_bib31","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2024.09.015_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5603\/CJ.a2021.0001","article-title":"Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update","volume":"28","author":"Borghi","year":"2021","journal-title":"Cardiol J"},{"key":"10.1016\/j.numecd.2024.09.015_bib33","first-page":"1","article-title":"Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training","volume":"3","author":"Roberts","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.numecd.2024.09.015_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1570161114666161007164510","article-title":"Link between metabolic syndrome and insulin resistance","volume":"15","author":"Gluvic","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.numecd.2024.09.015_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2024.09.015_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2024.09.015_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fcell.2020.00703","article-title":"Bergenin as a novel urate-lowering therapeutic strategy for hyperuricemia","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.numecd.2024.09.015_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2021.11.034","article-title":"Silencing TXNIP ameliorates high uric acid-induced insulin resistance via the IRS2\/AKT and Nrf2\/HO-1 pathways in macrophages","volume":"178","author":"Yu","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.numecd.2024.09.015_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fendo.2018.00098","article-title":"Uric acid impairs insulin signaling by promoting Enpp1 binding to insulin receptor in human umbilical vein endothelial cells","volume":"9","author":"Tassone","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.numecd.2024.09.015_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biochi.2015.06.025","article-title":"Uric acid as a modulator of glucose and lipid metabolism","volume":"116","author":"Lima","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.numecd.2024.09.015_bib41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","article-title":"Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes","volume":"94","author":"Choi","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.numecd.2024.09.015_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9304383","article-title":"High level of uric acid promotes atherosclerosis by targeting NRF2-mediated autophagy dysfunction and ferroptosis","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.numecd.2024.09.015_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system","volume":"26","author":"Corry","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2024.09.015_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications","volume":"59","author":"Puddu","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.numecd.2024.09.015_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.143460","article-title":"Wastewater-based prevalence trends of gout in an Australian community over a period of 8 years","volume":"759","author":"Ahmed","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.numecd.2024.09.015_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11926-016-0594-8","article-title":"Gout classification criteria: update and implications","volume":"18","author":"Vargas-Santos","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.numecd.2024.09.015_bib47","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/acr.24576","article-title":"Relationship between changing body mass index and serum uric acid alteration among clinically apparently healthy Korean men","volume":"74","author":"Hwang","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.numecd.2024.09.015_bib48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4158\/EP-2018-0426","article-title":"Association between serum uric acid level and body mass index in sex- and age-specific groups in southwestern China","volume":"25","author":"Liu","year":"2019","journal-title":"Endocr Pract"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324003648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324003648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:38:13Z","timestamp":1737319093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324003648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0939475324003648"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.09.015","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum uric acid and mortality in metabolic dysfunction-associated steatotic liver disease: Subgroup differences","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}